AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32010994 — intervention group
Group type: COMPARATOR
Intervention: Commonly used equations for estimating REE
Number of subjects: 270
Study 35834340 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicycle ergometer exercise at the rehabilitation center under medical staff monitoring
Number of subjects: 67
Study 35834340 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise (HBE) by dosed walking
Number of subjects: 67
Study 35834340 — intervention group
Group type: COMPARATOR
Intervention: Both groups (Bicycle ergometer and HBE)
Number of subjects: 67
Study 33634858 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant therapy (NAT) with imatinib, median duration 6.3 months
Number of subjects: 16308
Study 33634858 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant therapy (NAT)
Number of subjects: 16308
Study 33634858 — intervention group
Group type: COMPARATOR
Intervention: Upfront resection (UR)
Number of subjects: 16308
Study 33634858 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant therapy (NAT) vs Upfront resection (UR)
Number of subjects: 16308
Study 33142500 — intervention group
Group type: EXPERIMENTAL
Intervention: 8% corn resistant starch (RS)
Number of subjects: 320
Study 33142500 — intervention group
Group type: EXPERIMENTAL
Intervention: 12% corn resistant starch (RS)
Number of subjects: 320
Study 33142500 — intervention group
Group type: COMPARATOR
Intervention: NC and CS (control groups)
Number of subjects: 320
Study 34906371 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive distal pancreatectomy
Number of subjects: 247
Study 34906371 — intervention group
Group type: COMPARATOR
Intervention: Open distal pancreatectomy
Number of subjects: 247
Study 34221852 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional information about benefits and harms of cervical cancer screening
Number of subjects: 2144
Study 34221852 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior Pap-test
Number of subjects: 2144
Study 34221852 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower income
Number of subjects: 2144
Study 36293748 — intervention group
Group type: EXPERIMENTAL
Intervention: ANZANSI intervention (combination of family economic empowerment and multiple family group family strengthening)
Number of subjects: 20
Study 33515087 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiological reports made with clinical information
Number of subjects: 410
Study 33515087 — intervention group
Group type: COMPARATOR
Intervention: Radiological reports made without clinical information
Number of subjects: 410
Study 33515087 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical management based on radiological diagnoses with clinical information
Number of subjects: 410
Study 33515087 — intervention group
Group type: COMPARATOR
Intervention: Clinical management based on radiological diagnoses without clinical information
Number of subjects: 410
Study 34431828 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month lifestyle intervention (aerobic training sessions combined with resistance training)
Number of subjects: 98
Study 34431828 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 98
Study 34622750 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary supplement of 4% ARA
Number of subjects: 25
Study 34622750 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary supplement of ARA (various levels)
Number of subjects: 25
Study 35481708 — intervention group
Group type: EXPERIMENTAL
Intervention: Center-based early childhood development intervention including individual parenting training, group activities, and open play space in village parenting centers.
Number of subjects: 1664
Study 35481708 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup analyses by caregiver socioeconomic status and identity (mother vs. grandmother).
Number of subjects: 1664
Study 34960037 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation
Number of subjects: 68
Study 34960037 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 36084566 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 244
Study 36084566 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin
Number of subjects: 244
Study 33453192 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy combined with oral medication and exercise
Number of subjects: 32
Study 33453192 — intervention group
Group type: COMPARATOR
Intervention: Sham extracorporeal shock wave therapy combined with oral medication and exercise
Number of subjects: 32
Study 35107401 — intervention group
Group type: EXPERIMENTAL
Intervention: Humor-based contraception education (one-time education of 45-60 minutes)
Number of subjects: 88
Study 35107401 — intervention group
Group type: COMPARATOR
Intervention: Standard contraception education (one-time education of 45-60 minutes)
Number of subjects: 88
Study 34033205 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents under Pressure (PuP) programme
Number of subjects: 100
Study 34033205 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 100
Study 35351353 — intervention group
Group type: EXPERIMENTAL
Intervention: Online self-help using cognitive-behavioral therapy and positive psychology principles (n = 301)
Number of subjects: 585
Study 35351353 — intervention group
Group type: COMPARATOR
Intervention: Referral to usual care (n = 284)
Number of subjects: 585
Study 34196269 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy plus standardised medical care
Number of subjects: 368
Study 34196269 — intervention group
Group type: COMPARATOR
Intervention: Standardised medical care alone
Number of subjects: 368
Study 32883262 — intervention group
Group type: EXPERIMENTAL
Intervention: Unmet need for family planning services
Number of subjects: 535
Study 32883262 — intervention group
Group type: EXPERIMENTAL
Intervention: Spacing methods
Number of subjects: 535
Study 32883262 — intervention group
Group type: EXPERIMENTAL
Intervention: Limiting methods
Number of subjects: 535
Study 32883262 — intervention group
Group type: EXPERIMENTAL
Intervention: Determinants of unmet need
Number of subjects: 535
Study 34609052 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretraining of basic psycho-motor skills (Navigation Training level 2 and Bimanual Training level 3)
Number of subjects: 68
Study 34609052 — intervention group
Group type: EXPERIMENTAL
Intervention: Procedure-specific modules (Posterior Hyaloid level 3 and ILM Peeling level 3)
Number of subjects: 68
Study 34609052 — intervention group
Group type: EXPERIMENTAL
Intervention: ILM peeling level 3 starting score
Number of subjects: 68
Study 32824061 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness treatment (flow meditation)
Number of subjects: 51
Study 32824061 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 51
Study 33200213 — intervention group
Group type: COMPARATOR
Intervention: PVI alone
Number of subjects: 512
Study 33200213 — intervention group
Group type: EXPERIMENTAL
Intervention: PVI plus CFAE and/or linear ablation
Number of subjects: 512
Study 32779416 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics + bee products
Number of subjects: 104
Study 32779416 — intervention group
Group type: EXPERIMENTAL
Intervention: Bee products
Number of subjects: 104
Study 32779416 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 32779416 — intervention group
Group type: COMPARATOR
Intervention: Antibiotics
Number of subjects: 104
Study 33671743 — intervention group
Group type: EXPERIMENTAL
Intervention: Didactic video based on the mental health Gap Action Programme (mhGAP)
Number of subjects: 307
Study 33671743 — intervention group
Group type: EXPERIMENTAL
Intervention: Service user video about living with mental illness
Number of subjects: 307
Study 33671743 — intervention group
Group type: COMPARATOR
Intervention: Control condition with no videos
Number of subjects: 307
Study 33671743 — intervention group
Group type: EXPERIMENTAL
Intervention: Service user video describing depression and psychosis
Number of subjects: 307
Study 33671743 — intervention group
Group type: EXPERIMENTAL
Intervention: Didactic video addressing depression and psychosis
Number of subjects: 307
Study 33762229 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 12200
Study 33762229 — intervention group
Group type: COMPARATOR
Intervention: Low-molecular-weight heparin (LMWH)
Number of subjects: 12200
Study 32025843 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfast® beverage
Number of subjects: 47
Study 32025843 — intervention group
Group type: EXPERIMENTAL
Intervention: Gatorade Thirst Quencher® beverage
Number of subjects: 47
Study 32025843 — intervention group
Group type: COMPARATOR
Intervention: Fasting control
Number of subjects: 47
Study 35266127 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive, multidisciplinary transitional care (TC) services
Number of subjects: 653
Study 35266127 — intervention group
Group type: COMPARATOR
Intervention: Routine coordination of post‐discharge care (RC)
Number of subjects: 653
Study 32538865 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly ParkinSong
Number of subjects: 75
Study 32538865 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly ParkinSong
Number of subjects: 75
Study 32538865 — intervention group
Group type: EXPERIMENTAL
Intervention: ParkinSong participants
Number of subjects: 75
Study 32538865 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregivers attending ParkinSong
Number of subjects: 75
Study 32538865 — intervention group
Group type: COMPARATOR
Intervention: Monthly control
Number of subjects: 75
Study 32538865 — intervention group
Group type: COMPARATOR
Intervention: Weekly control
Number of subjects: 75
Study 34453873 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% hydrogen peroxide (HP) gel with prefilled trays (PT) for 30 minutes
Number of subjects: 60
Study 34453873 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% hydrogen peroxide (HP) gel with customized trays (CT) for 30 minutes
Number of subjects: 60
Study 34453873 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% carbamide peroxide (CP) gel with customized trays (CT) for 2 hours
Number of subjects: 60
Study 34453873 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% carbamide peroxide (CP) gel with customized trays (CT) for 8 hours
Number of subjects: 60
Study 34453873 — intervention group
Group type: COMPARATOR
Intervention: Conventional nightguard vital bleaching (10% CP)
Number of subjects: 60
Study 35866767 — intervention group
Group type: EXPERIMENTAL
Intervention: PCIA with low-dose naloxone admixture at 0.2 μg·kg‐1·h‐1 (Group B)
Number of subjects: 120
Study 35866767 — intervention group
Group type: EXPERIMENTAL
Intervention: PCIA with naloxone admixture at 0.4 μg·kg‐1·h‐1 (Group C)
Number of subjects: 120
Study 35866767 — intervention group
Group type: EXPERIMENTAL
Intervention: PCIA with naloxone admixture at 0.6 μg·kg‐1·h‐1 (Group D)
Number of subjects: 120
Study 35866767 — intervention group
Group type: EXPERIMENTAL
Intervention: PCIA with naloxone admixture (Group B/C/D)
Number of subjects: 120
Study 35866767 — intervention group
Group type: COMPARATOR
Intervention: Control group (PCIA with no naloxone, Group A)
Number of subjects: 120
Study 34407811 — intervention group
Group type: EXPERIMENTAL
Intervention: INT-DPM (group-based lifestyle intervention with additional support from trained volunteers)
Number of subjects: 432
Study 34407811 — intervention group
Group type: EXPERIMENTAL
Intervention: INT (group-based lifestyle intervention)
Number of subjects: 432
Study 34407811 — intervention group
Group type: COMPARATOR
Intervention: CON (control arm)
Number of subjects: 432
Study 34407811 — intervention group
Group type: EXPERIMENTAL
Intervention: INT-DPM (in participants < 65 years old)
Number of subjects: 432
Study 34407811 — intervention group
Group type: EXPERIMENTAL
Intervention: INT-DPM (in participants > 65 years old)
Number of subjects: 432
Study 34407811 — intervention group
Group type: EXPERIMENTAL
Intervention: INT-DPM (with oral hypoglycaemic medication)
Number of subjects: 432
Study 32543212 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness and modified medical yoga (MMY)
Number of subjects: 20
Study 32543212 — intervention group
Group type: COMPARATOR
Intervention: Theory (T)
Number of subjects: 20
Study 35195738 — intervention group
Group type: EXPERIMENTAL
Intervention: Single carbon dioxide (CO2) laser maintenance treatment
Number of subjects: 131
Study 35195738 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment control group
Number of subjects: 131
Study 34405232 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 1800
Study 34405232 — intervention group
Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 1800
Study 32026729 — intervention group
Group type: EXPERIMENTAL
Intervention: CNS Vital Signs (sandbagging group)
Number of subjects: 25
Study 32026729 — intervention group
Group type: COMPARATOR
Intervention: CNS Vital Signs (control group)
Number of subjects: 25
Study 36495185 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine inhalation spray (one puff per 12 hours for 7 days)
Number of subjects: 250
Study 36495185 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment alone
Number of subjects: 250
Study 33588060 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination group (PDT + isotretinoin 10 mg twice a day for 3 months)
Number of subjects: 70
Study 33588060 — intervention group
Group type: COMPARATOR
Intervention: PDT group (PDT alone)
Number of subjects: 70
Study 32453510 — intervention group
Group type: EXPERIMENTAL
Intervention: Attitude/negative messages
Number of subjects: 287
Study 32453510 — intervention group
Group type: EXPERIMENTAL
Intervention: Norm/positive messages
Number of subjects: 287
Study 32453510 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective norm
Number of subjects: 287
Study 35272729 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric toy car
Number of subjects: 48
Study 35272729 — intervention group
Group type: COMPARATOR
Intervention: Control (gurney transport)
Number of subjects: 48
Study 33677858 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily cigarette smoking
Number of subjects: 5640
Study 33677858 — intervention group
Group type: COMPARATOR
Intervention: Non-smokers (control group)
Number of subjects: 5640
Study 33677858 — intervention group
Group type: EXPERIMENTAL
Intervention: Female smokers
Number of subjects: 5640
Study 33677858 — intervention group
Group type: EXPERIMENTAL
Intervention: Male smokers
Number of subjects: 5640
Study 32502705 — intervention group
Group type: EXPERIMENTAL
Intervention: Transversus abdominis plane block with dexmedetomidine (1 μg/kg)
Number of subjects: 0
Study 32502705 — intervention group
Group type: EXPERIMENTAL
Intervention: Transversus abdominis plane block without dexmedetomidine
Number of subjects: 0
Study 32502705 — intervention group
Group type: COMPARATOR
Intervention: Morphine intravenous patient‐controlled analgesia (Control group)
Number of subjects: 0
Study 35959737 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate, lamivudine, and dolutegravir (TLD)
Number of subjects: 184
Study 35959737 — intervention group
Group type: COMPARATOR
Intervention: Previous regimens (not specified)
Number of subjects: 184
Study 33843133 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy followed by pelvic re-irradiation
Number of subjects: 186
Study 33843133 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy alone
Number of subjects: 186
Study 34235972 — intervention group
Group type: EXPERIMENTAL
Intervention: Reresection within 6 weeks after initial en bloc resection
Number of subjects: 115
Study 34235972 — intervention group
Group type: COMPARATOR
Intervention: Non-reresection after initial en bloc resection
Number of subjects: 115
Study 33259482 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B12 supplementation (2 μg daily for 12 months)
Number of subjects: 600
Study 33259482 — intervention group
Group type: COMPARATOR
Intervention: Placebo (daily for 12 months)
Number of subjects: 600
Study 34865016 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 500 mg/day for 12 weeks
Number of subjects: 148
Study 34865016 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 148
Study 36271512 — intervention group
Group type: EXPERIMENTAL
Intervention: Torque technique
Number of subjects: 160
Study 36271512 — intervention group
Group type: EXPERIMENTAL
Intervention: Fanning technique
Number of subjects: 160
Study 36271512 — intervention group
Group type: COMPARATOR
Intervention: Standard technique
Number of subjects: 160
Study 36271512 — intervention group
Group type: EXPERIMENTAL
Intervention: Torque and fanning techniques combined
Number of subjects: 160
Study 33285652 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted therapy (RT) for 30 minutes twice a day for 2 weeks
Number of subjects: 45
Study 33285652 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation (CR) for 30 minutes twice a day for 2 weeks
Number of subjects: 45
Study 616675811 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditionally made sourdough‐leavened whole‐grain bread
Number of subjects: 0
Study 616675811 — intervention group
Group type: COMPARATOR
Intervention: Industrially made white bread
Number of subjects: 0
Study 616675811 — intervention group
Group type: EXPERIMENTAL
Intervention: Both bread types
Number of subjects: 0
Study 616675811 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbiome data
Number of subjects: 0
Study 35385097 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-session pain management skills intervention
Number of subjects: 0
Study 35385097 — intervention group
Group type: COMPARATOR
Intervention: Single-session health education intervention
Number of subjects: 0
Study 35385097 — intervention group
Group type: COMPARATOR
Intervention: 8 sessions of cognitive behavioral therapy
Number of subjects: 0
Study 32251039 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led education and cardiovascular risk factor modification with motivational interviewing and electronic decision support tool, 1 face-to-face session and 4 follow-up calls over 3 months.
Number of subjects: 72
Study 32251039 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care).
Number of subjects: 72
Study 32251039 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led education and cardiovascular risk factor modification with motivational interviewing and electronic decision support tool.
Number of subjects: 72
Study 35709172 — intervention group
Group type: EXPERIMENTAL
Intervention: OVIEW-M sperm test
Number of subjects: 200
Study 35709172 — intervention group
Group type: COMPARATOR
Intervention: Standard microscope examination
Number of subjects: 200
Study 34061332 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass ionomer-based fissure sealant (Fuji Triage®)
Number of subjects: 198
Study 34061332 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin-based fissure sealant (Clinpro™)
Number of subjects: 198
Study 34061332 — intervention group
Group type: EXPERIMENTAL
Intervention: Amorphous calcium phosphate-containing fissure sealant (Aegis®)
Number of subjects: 198
Study 34061332 — intervention group
Group type: COMPARATOR
Intervention: Control group (saliva contamination)
Number of subjects: 198
Study 35332291 — intervention group
Group type: EXPERIMENTAL
Intervention: Optical coherence tomography (OCT)
Number of subjects: 626
Study 35332291 — intervention group
Group type: COMPARATOR
Intervention: Slit lamp indirect ophthalmoscopy (SLIO)
Number of subjects: 626
Study 34323164 — intervention group
Group type: EXPERIMENTAL
Intervention: Selinexor 60 mg twice weekly
Number of subjects: 175
Study 34323164 — intervention group
Group type: COMPARATOR
Intervention: Physician’s choice (PC) treatment
Number of subjects: 175
Study 34323164 — intervention group
Group type: EXPERIMENTAL
Intervention: Selinexor
Number of subjects: 175
Study 32598447 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic fat injections (3 injections according to Coleman's technique) after radiotherapy and before expander removal with definitive implant insertion.
Number of subjects: 60
Study 32598447 — intervention group
Group type: COMPARATOR
Intervention: Surgery without lipofilling (Control Group B).
Number of subjects: 60
Study 36244120 — intervention group
Group type: EXPERIMENTAL
Intervention: Animal Fun program (thirty minutes, three times a week)
Number of subjects: 119
Study 36244120 — intervention group
Group type: COMPARATOR
Intervention: Standard curriculum involving general physical activity (Control)
Number of subjects: 119
Study 34895165 — intervention group
Group type: EXPERIMENTAL
Intervention: Postcard-sized message (outsert)
Number of subjects: 185526
Study 34895165 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer narrative article (insert)
Number of subjects: 185526
Study 34895165 — intervention group
Group type: COMPARATOR
Intervention: Both insert and outsert
Number of subjects: 185526
Study 34895165 — intervention group
Group type: COMPARATOR
Intervention: Neither insert nor outsert
Number of subjects: 185526
Study 33678098 — intervention group
Group type: EXPERIMENTAL
Intervention: Liberal fluid regime
Number of subjects: 40
Study 33678098 — intervention group
Group type: COMPARATOR
Intervention: Strict fluid regime
Number of subjects: 40
Study 32222782 — intervention group
Group type: EXPERIMENTAL
Intervention: Metaphor-based visual representations of pharmaceutical pollution risks
Number of subjects: 20
Study 32222782 — intervention group
Group type: COMPARATOR
Intervention: Non-metaphor visual representations of pharmaceutical pollution risks
Number of subjects: 20
Study 35106315 — intervention group
Group type: EXPERIMENTAL
Intervention: MHAA4549A (3600 mg or 8400 mg)
Number of subjects: 125
Study 35106315 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study 35106315 — intervention group
Group type: EXPERIMENTAL
Intervention: MHAA4549A
Number of subjects: 125
Study 33865147 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory targeted cognitive training (TCT) for 40 hours over 16 weeks
Number of subjects: 43
Study 33865147 — intervention group
Group type: COMPARATOR
Intervention: Computer games control condition (CG) for 40 hours over 16 weeks
Number of subjects: 43
Study 34076981 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methotrexate combined with rituximab (HD-MTX + R)
Number of subjects: 108
Study 34076981 — intervention group
Group type: COMPARATOR
Intervention: High-dose methotrexate combined with whole brain radiotherapy (WBRT)
Number of subjects: 108
Study 36484844 — intervention group
Group type: EXPERIMENTAL
Intervention: piTBS
Number of subjects: 34
Study 36484844 — intervention group
Group type: COMPARATOR
Intervention: iTBS
Number of subjects: 34